Key Stats for CAVA Stock
- Current Price: $66.95
- Target Price (Mid): ~$205
- Street Target: ~$85
- Potential Total Return: ~204%
- Annualized IRR: ~29% / year
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
CAVA Group (CAVA) did the hard part. On August 11, the Mediterranean chain reported second-quarter revenue of $368.4 million, up 31.3% from a year earlier, with same-restaurant sales up 9% and adjusted EPS of $0.19. Every headline line cleared Wall Street’s estimate, the stock jumped 14.24% the next session, and then it gave the move back. Shares closed at $66.95 on August 27, below where they traded once the pop faded.
Most desks trimmed their price targets rather than chase the beat: TD Cowen went to $85 from $100, KeyBanc to $95 from $110, Mizuho to $70 from $85, DA Davidson to $75 from $84. A few moved the other way, with RBC and Wolfe nudging targets up and Baird upgrading to strong buy, but the cuts dominated. A company beat expectations and its analysts, on balance, got more cautious.
The Beat Was Real, but the Guide Prices a Slowdown
Revenue of $368.4 million cleared the roughly $360 million Street estimate, adjusted EBITDA rose 30% to $54.7 million, and net income grew to $23 million from $18.4 million. The 9% comp was built on 5.3% traffic, meaning guests came more often rather than just paying more. That traffic line is what separates CAVA from a category where Sweetgreen posted same-store sales of roughly negative 13% in the first quarter of 2026.
CAVA reiterated full-year same-restaurant sales growth of 4.5% to 6.5%, unchanged against a 9.7% first quarter and a 9% second quarter, which forces a sharp back-half slowdown on paper. CFO Tricia Tolivar framed it as caution, not weakness, calling it “a very prudent assumption regarding the duration of the Cyclospora impact itself and what that will mean for the business,” and noting nothing in current trends points to the low end. That external produce scare briefly pushed comps to flat-to-positive before they recovered to mid-single digits week by week, so the dip management is guiding around is already fading in the data.
See historical and forward estimates for CAVA stock (It’s free!) >>>
Why the Targets Fell as Results Rose
On the call, Tolivar flagged several margin headwinds hitting at once: input costs from the national salmon launch, fuel surcharges, and the pre-marinated chicken rollout, all pushing food, beverage, and packaging costs higher as a percent of revenue through year-end. Restaurant-level margin already slipped to 25.7% from 26.3%, and the full-year guide sits at 23.7% to 24.3%. For a richly valued stock, a thinner near-term margin path is enough to knock $10 or $15 off a target.
The pre-marinated chicken decision is where long-term logic diverges from short-term optics. Rather than bank the labor savings, management is reinvesting the freed-up hours into service. Schulman was explicit: “Take those 3 or 4 hours that you’re saving in manual prep and invest that in our guests and the hospitality and the service and the table touches.” That compresses the margin now to build traffic later, exactly the trade a multiple near 100 times forward earnings punishes on a quarterly view.
CAVA trades around 102 times NTM earnings and 36.6 times NTM EV/EBITDA. Chipotle sits near 29 times forward earnings and 20.9 times forward EBITDA; Shake Shack sits near 56.5 times earnings and 14.2 times EBITDA. CAVA carries the steepest multiple of the three by a wide margin, defensible only if it keeps compounding revenue near 20% and expanding units at a double-digit clip. That is precisely what a downgraded desk is unwilling to underwrite at this price.
See how CAVA performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $66.95
- Target Price (Mid): ~$205
- Potential Total Return: ~204%
- Annualized IRR: ~29% / year
See analysts’ growth forecasts and price targets for CAVA stock (It’s free!) >>>
TIKR’s mid-case scenario points to a target near $205, implying roughly 204% total return and about a 29% annualized IRR. It rests on two revenue engines the quarter reinforced: unit growth, with 75 to 77 net new restaurants planned this year at new-restaurant productivity above 100%, and traffic-led same-restaurant sales. The mid case assumes revenue compounding around 19% with net income margin widening toward roughly 7%, carried by operating leverage on a larger base.
The primary risk is the multiple, not the business. If revenue grows near 20% but the market reprices CAVA toward a mature restaurant multiple, the stock can stall even as fundamentals deliver, which is most of what happened in 2026. The upside: traffic-led comps and above-100% new-unit productivity keep compounding earnings while the multiple holds, carrying the stock toward the model’s target. The downside: back-half margin pressure and a decelerating comp hand the market a reason to compress the multiple further, and a stock near 100 times earnings has a long way to fall before valuation offers support. The model output is a scenario built on those assumptions, not a promise.
Conclusion
The next real test is the third-quarter print in early November, and one line settles it: same-restaurant sales against management’s mid-single-digit trajectory. A comp holding at mid-single digits or better with positive traffic says the Cyclospora dip was the pause management described, and the guide was conservatism. A comp sliding toward flat, paired with a restaurant-level margin falling below the 23.7% floor, says the target cuts were early rather than wrong. The business is compounding faster than almost anything in its category. Whether that earns a near-100-times multiple is the only question that has ever mattered here, and November’s traffic line is where it gets answered.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in CAVA?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up CAVA, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track CAVA alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
